GO:1990706 MAD1 complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990706 (MAD1 complex) is a cellular component defined as a protein complex involved in the assembly of the mitotic checkpoint complex (MCC), which inhibits the anaphase promoting complex/cyclosome (APC/C).
• The MAD1 complex is a homodimer that localizes to unattached kinetochores and serves as a scaffold for MCC assembly.
• MAD1 interacts with MAD2, BUB1, BUBR1, CDC20, and other checkpoint proteins to catalyze MCC formation.
• Phosphorylation of MAD1 by BUB1 and other kinases regulates its catalytic activity and kinetochore recruitment.
• Dysregulation of MAD1 complex function leads to chromosomal instability and is implicated in various cancers.
• Research on MAD1 complex uses knockout, point mutation, knock-in, and overexpression models combined with imaging, proteomics, and CRISPR screening.
Description
The MAD1 complex (GO:1990706) is a cellular component that plays a central role in the spindle assembly checkpoint (SAC), a surveillance mechanism ensuring accurate chromosome segregation during mitosis. This complex is defined as a protein complex involved in the assembly of the mitotic checkpoint complex (MCC), which in turn inhibits the anaphase promoting complex/cyclosome (APC/C). The MAD1 complex is a homodimer that localizes to unattached kinetochores and acts as a scaffold for MCC assembly. Researchers study the MAD1 complex to understand how cells maintain genomic stability and how its dysfunction contributes to diseases such as cancer. The complex is highly conserved and its structural flexibility is critical for its catalytic function.
MAD1 complex At A Glance
| GO ID | GO:1990706 |
|---|---|
| GO term | MAD1 complex |
| Ontology | cellular_component |
| Synonym | MAD1 homodimer |
| Major function | Assembly of the mitotic checkpoint complex (MCC) and inhibition of APC/C |
| Location | Kinetochore outer corona |
| Subunits | MAD1 homodimer, associated with MAD2, BUB1, BUBR1, CDC20 |
| Conservation | Highly conserved from yeast to humans |
What Is GO:1990706?
According to the Gene Ontology, GO:1990706 (MAD1 complex) is a protein complex involved in the assembly of the mitotic checkpoint complex that in turn inhibits the anaphase promoting complex/cyclosome (APC/C). It is synonymous with MAD1 homodimer. This complex is a cellular component located at kinetochores and functions as a scaffold to facilitate the interaction between MAD2, BUBR1, BUB3, and CDC20, leading to MCC formation and APC/C inhibition.
Why Is MAD1 complex Important in Cell Biology?
The MAD1 complex is essential for the spindle assembly checkpoint, a critical safeguard against aneuploidy. Its ability to catalyze MCC assembly ensures that cells do not proceed to anaphase until all chromosomes are properly attached to the spindle. Dysregulation of MAD1 complex components leads to chromosomal instability, a hallmark of cancer, and has been linked to tumor progression and chemoresistance. Understanding the MAD1 complex provides insights into basic mitotic mechanisms and offers potential targets for cancer therapy.
• Prevents aneuploidy by ensuring proper chromosome segregation.
• Acts as a catalytic scaffold for MCC assembly, accelerating checkpoint signaling.
• Its dysfunction is associated with various cancers, including breast cancer.
• Phosphorylation of MAD1 regulates its activity and kinetochore localization.
• MAD1 interacts with multiple checkpoint proteins, making it a hub for signaling.
• Structural flexibility of MAD1 is crucial for its catalytic function.
• MAD1 complex is a target for understanding chemoresistance in cancer.
• Research on MAD1 complex informs the development of mitotic inhibitors.
• MAD1 complex components are conserved, allowing model organism studies.
• Its role in MCC assembly makes it a key node in cell cycle regulation.
Structure and Composition of MAD1 complex
MAD1 Homodimer as the Core Scaffold
In simple terms: The MAD1 complex is primarily made of two MAD1 molecules stuck together, forming a homodimer.
The MAD1 complex is a homodimer of MAD1 proteins, which forms an elongated structure with coiled-coil domains. This homodimer serves as a scaffold that recruits other checkpoint proteins to unattached kinetochores. Structural studies have revealed that MAD1 adopts a flexible conformation, allowing it to interact with multiple partners simultaneously.
Interaction with MAD2 and MCC Components
In simple terms: MAD1 grabs onto MAD2 and other proteins to build the mitotic checkpoint complex.
MAD1 directly binds to MAD2, facilitating its conversion to the active closed conformation that can inhibit CDC20. The MAD1-MAD2 interaction is essential for MCC assembly, as MAD1 acts as a template for MAD2 activation. Additionally, MAD1 interacts with BUB1, BUBR1, and CDC20 to coordinate MCC formation.
Kinetochore Recruitment and Outer Corona Localization
In simple terms: MAD1 is brought to the kinetochore by other proteins like the RZZ complex and KNL1.
MAD1 localization to kinetochores depends on the RZZ complex and the N-terminus of KNL1. The outer corona, a fibrous structure at kinetochores, is where MAD1 accumulates to catalyze MCC assembly. This recruitment is cell-cycle regulated and is critical for checkpoint activation.
Phosphorylation and Regulatory Modifications
In simple terms: Adding phosphate groups to MAD1 changes its activity and interactions.
Phosphorylation of MAD1 by BUB1 and other kinases modulates its ability to bind MAD2 and catalyze MCC assembly. Specifically, phosphorylated MAD1 juxtaposes BUB1 and CDC20 to promote catalytic MCC assembly. These modifications are dynamic and regulate checkpoint signaling.
Structural Flexibility and Catalytic Mechanism
In simple terms: MAD1 can bend and change shape to help build the MCC faster.
The structural flexibility of MAD1 allows it to adopt multiple conformations that facilitate the transfer of MAD2 to CDC20. This flexibility is essential for the catalytic acceleration of MCC assembly, as it enables MAD1 to simultaneously engage multiple substrates. Mutations that rigidify MAD1 impair checkpoint function.
Key Genes Involved in GO:1990706 MAD1 complex
The MAD1 complex involves several key genes and proteins that are critical for its assembly and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAD1L1 | Core component of the MAD1 complex; scaffold for MCC assembly | Mutations linked to cancer; target for knockout studies |
| MAD2L1 | Binds MAD1 and is activated for MCC formation | Key effector of checkpoint; knockout causes aneuploidy |
| BUB1 | Phosphorylates MAD1 and regulates its activity | Kinase essential for checkpoint; point mutations affect catalysis |
| BUB1B | BUBR1, part of MCC, interacts with MAD1 complex | Mutations cause mosaic variegated aneuploidy |
| CDC20 | Target of MCC inhibition; interacts with MAD1 | Overexpression linked to cancer; substrate for MCC |
| KNL1 | Recruits MAD1 to kinetochores via N-terminus | Knockout disrupts MAD1 localization |
| ZW10 | Part of RZZ complex, required for MAD1 kinetochore targeting | Knockdown affects checkpoint |
| MAD1L1 (phospho-mutant) | Phosphorylation-deficient or -mimetic forms | Used to study regulation |
| MAD2L1 (open/closed) | Conformational states regulated by MAD1 | Point mutations lock conformations |
| BUB3 | Part of MCC, interacts with BUBR1 and MAD1 | Knockout impairs checkpoint |
| CENP-E | Kinesin involved in kinetochore recruitment of MAD1 | Depletion affects outer corona |
| MPS1 | Kinase that phosphorylates KNL1 and regulates MAD1 | Inhibitors used to study checkpoint |
| Aurora B | Regulates kinetochore-microtubule attachments and MAD1 | Inhibitors affect checkpoint |
| Cyclin B1 | Forms complex with MAD1, regulates mitosis | Overexpression alters checkpoint |
| PP2A | Phosphatase that may regulate MAD1 phosphorylation | Involved in checkpoint silencing |
| TRIP13 | AAA-ATPase that regulates MAD2 and MAD1 | Knockout affects MCC disassembly |
| p31comet | MAD2-binding protein that inactivates checkpoint | Overexpression silences checkpoint |
How Is MAD1 complex Regulated?
The MAD1 complex is regulated by phosphorylation events, particularly by BUB1 kinase, which phosphorylates MAD1 to promote MCC assembly. Additionally, the localization of MAD1 to kinetochores is regulated by the RZZ complex and KNL1. The structural flexibility of MAD1 is modulated by its interactions with MAD2 and other partners, and this flexibility is essential for its catalytic function. Checkpoint silencing involves disassembly of the MAD1 complex, which is mediated by TRIP13 and p31comet.
MAD1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAD1L1 | Breast cancer, chromosomal instability | Knockout in MCF7 cells; overexpression in normal cells |
| BUB1B | Mosaic variegated aneuploidy | Patient-derived fibroblasts; knock-in of patient mutations |
| MAD2L1 | Cancer, aneuploidy | Knockout in HCT116; point mutations to lock conformation |
| CDC20 | Cancer, chemoresistance | Overexpression in HeLa; knockout in RPE1 |
| TRIP13 | Cancer, checkpoint defects | Knockout in cancer cell lines; overexpression |
MAD1 Complex and Cancer
Dysregulation of the MAD1 complex leads to chromosomal instability (CIN), a hallmark of many cancers. Reduced expression of MAD1 or its partners can cause aneuploidy and promote tumorigenesis. In breast cancer, the Sin3A/MAD1 complex acts as a repressor of retinoic acid receptor beta, contributing to cancer cell proliferation. Moreover, MAD1-cyclin B1 complex function is linked to chemoresistance in cancer cells.
MAD1 Complex in Mosaic Variegated Aneuploidy
Mutations in BUBR1 (BUB1B), a component of the MCC that interacts with the MAD1 complex, cause mosaic variegated aneuploidy (MVA), a rare genetic disorder characterized by chromosomal instability and cancer predisposition. Although direct mutations in MAD1L1 are less common, its dysfunction can phenocopy aspects of MVA.
MAD1 Complex and Neurodegeneration
Emerging evidence suggests that mitotic checkpoint defects, including those involving the MAD1 complex, may contribute to neurodegeneration through aneuploidy in neurons. However, direct links require further investigation.
From MAD1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of MAD1 phosphorylation in MCC assembly? | Point mutation (phospho-deficient/mimetic) knock-in of MAD1L1 |
| How does MAD1 localization affect checkpoint? | Knockout of KNL1 or RZZ components; tagged knock-in of MAD1 |
| Does MAD1 overexpression cause aneuploidy? | Overexpression of MAD1L1 in cell lines |
| What is the effect of MAD1 loss on cell cycle? | CRISPR knockout of MAD1L1 in cancer cells |
| How does MAD1 interact with cyclin B1? | Knock-in of tagged MAD1; co-immunoprecipitation |
| Can MAD1 mutations drive tumorigenesis? | Knock-in of cancer-associated mutations in mouse models |
How to Study the MAD1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Kinetochore localization and dynamics of MAD1 | Assess checkpoint activation |
| AP-MS | Protein interactions and modifications | Identify MAD1 complex components |
| Cryo-EM | High-resolution structure | Determine MAD1-MAD2 interface |
| Checkpoint assay | Mitotic arrest and APC/C inhibition | Evaluate MAD1 mutants |
| FRAP | Turnover kinetics of MAD1 at kinetochores | Measure binding dynamics |
| RNA-seq | Transcriptional changes upon MAD1 perturbation | Identify downstream pathways |
| CRISPR screening | Genome-wide identification of synthetic lethal partners | Find vulnerabilities in MAD1-mutant cells |
| Proximity ligation | In situ protein interactions | Validate MAD1-MAD2 binding |
Imaging and Live-Cell Analysis
Fluorescence microscopy of GFP-tagged MAD1 allows visualization of its kinetochore localization and dynamics during mitosis. Live-cell imaging combined with FRAP can measure MAD1 turnover at kinetochores.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry (AP-MS) identifies MAD1 interactors and their post-translational modifications. Proximity ligation assays can detect specific interactions in situ.
Structural Biology
Cryo-EM and X-ray crystallography have revealed the structure of MAD1 and its complexes with MAD2 and other partners. These studies inform mutational analyses.
Functional Assays
Checkpoint assays using live-cell imaging of chromosome segregation and APC/C activity measure MAD1 complex function. Knockout and rescue experiments validate specific domains.
How CRISPR Can Be Used to Study GO:1990706 MAD1 complex
Knockout
CRISPR knockout of MAD1L1 or its partners (e.g., MAD2L1, BUB1) in cell lines such as HeLa or HCT116 abolishes checkpoint function, leading to premature anaphase and aneuploidy. These models are used to study the consequences of checkpoint loss and to identify synthetic lethal interactions.
Point Mutation
Point mutations in MAD1L1 (e.g., phosphorylation site mutants) can be introduced via CRISPR to dissect the role of specific residues in MCC assembly. Such models help distinguish between catalytic and structural functions.
Knock-in
Knock-in of tagged MAD1 (e.g., GFP or HaloTag) allows real-time imaging of the complex at kinetochores. Knock-in of disease-associated mutations (e.g., in BUB1B) recapitulates patient phenotypes.
Overexpression
Overexpression of MAD1L1 or its binding partners (e.g., cyclin B1) can disrupt checkpoint regulation and promote aneuploidy. These models are useful for studying the effects of gene dosage on mitotic fidelity.
How EDITGENE Supports MAD1 complex Research
Researchers studying MAD1 complex-related genes often need to determine whether a candidate gene is causally involved in checkpoint function, chromosomal stability, or cancer progression. EDITGENE provides comprehensive CRISPR services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for MAD1 complex research.
Frequently Asked Questions About MAD1 complex
What is the MAD1 complex?
The MAD1 complex (GO:1990706) is a protein complex involved in assembling the mitotic checkpoint complex (MCC) to inhibit APC/C and ensure proper chromosome segregation.
What genes are involved in the MAD1 complex?
Key genes include MAD1L1, MAD2L1, BUB1, BUB1B, CDC20, and KNL1, which interact to form and regulate the complex.
Where is the MAD1 complex located?
It localizes to unattached kinetochores, specifically the outer corona, during mitosis.
What is the function of MAD1 in the spindle assembly checkpoint?
MAD1 acts as a scaffold to recruit MAD2 and catalyze its conversion to the MCC, which inhibits APC/C until all chromosomes are attached.
How is the MAD1 complex regulated?
It is regulated by phosphorylation (e.g., by BUB1) and by interactions with other proteins like the RZZ complex and KNL1.
What diseases are associated with MAD1 complex dysfunction?
Dysfunction leads to chromosomal instability and is linked to cancers such as breast cancer and to mosaic variegated aneuploidy.
What experimental models are used to study the MAD1 complex?
Knockout, point mutation, knock-in, and overexpression cell models, combined with imaging and proteomics, are commonly used.
How can CRISPR be used to study MAD1 complex genes?
CRISPR allows precise knockout, point mutation, knock-in, and overexpression of MAD1L1 and its partners to dissect their functions.
What is the MAD1 homodimer?
The MAD1 homodimer is the core structure of the MAD1 complex, consisting of two MAD1 molecules that form a scaffold for MCC assembly.
Why is the MAD1 complex important for cancer research?
Its role in maintaining genomic stability means that its dysfunction contributes to aneuploidy and cancer; targeting it may offer therapeutic strategies.
Conclusion
The MAD1 complex (GO:1990706) is a critical component of the spindle assembly checkpoint, orchestrating MCC assembly to prevent aneuploidy. Its structural flexibility and regulation by phosphorylation enable catalytic acceleration of checkpoint signaling. Dysregulation of the MAD1 complex is implicated in cancer and chromosomal instability disorders, making it a valuable target for research and therapeutic development. Advanced CRISPR models and bioinformatics tools from EDITGENE can accelerate discoveries in this field.
References
- 1. Fischer ES et al.. 2022. Juxtaposition of Bub1 and Cdc20 on phosphorylated Mad1 during catalytic mitotic checkpoint complex assembly.. Nat Commun 13(1):6381 PMID: 36289199
- 2. Dahiya NR et al.. 2022. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.. Cells 11(7) PMID: 35406744
- 3. Chen C et al.. 2023. The structural flexibility of MAD1 facilitates the assembly of the Mitotic Checkpoint Complex.. Nat Commun 14(1):1529 PMID: 36934097
- 4. Luo Y et al.. 2018. MAD1: Kinetochore Receptors and Catalytic Mechanisms.. Front Cell Dev Biol 6:51 PMID: 29868582
- 5. Houston J et al.. 2020. Rashomon at the kinetochore: Function(s) of the Mad1-cyclin B1 complex.. J Cell Biol 219(8) PMID: 32614383
- 6. Weber J et al.. 2024. A conserved CENP-E region mediates BubR1-independent recruitment to the outer corona at mitotic onset.. Curr Biol 34(5):1133-1141.e4 PMID: 38354735
- 7. Sethi S et al.. 2025. Interplay of kinetochores and catalysts drives rapid assembly of the mitotic checkpoint complex.. Nat Commun 16(1):4823 PMID: 40410156
- 8. Caldas GV et al.. 2015. The RZZ complex requires the N-terminus of KNL1 to mediate optimal Mad1 kinetochore localization in human cells.. Open Biol 5(11) PMID: 26581576
